KURA
Price
$9.36
Change
+$0.15 (+1.63%)
Updated
Jan 14 closing price
Capitalization
814.48M
47 days until earnings call
Intraday BUY SELL Signals
NVCT
Price
$8.41
Change
+$0.10 (+1.20%)
Updated
Jan 14 closing price
Capitalization
215.42M
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KURA vs NVCT

Header iconKURA vs NVCT Comparison
Open Charts KURA vs NVCTBanner chart's image
Kura Oncology
Price$9.36
Change+$0.15 (+1.63%)
Volume$899.09K
Capitalization814.48M
Nuvectis Pharma
Price$8.41
Change+$0.10 (+1.20%)
Volume$39.88K
Capitalization215.42M
KURA vs NVCT Comparison Chart in %
KURA
Daily Signal:
Gain/Loss:
NVCT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
KURA vs. NVCT commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KURA is a Hold and NVCT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (KURA: $9.36 vs. NVCT: $8.41)
Brand notoriety: KURA and NVCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KURA: 51% vs. NVCT: 46%
Market capitalization -- KURA: $814.48M vs. NVCT: $215.42M
KURA [@Biotechnology] is valued at $814.48M. NVCT’s [@Biotechnology] market capitalization is $215.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KURA’s FA Score shows that 1 FA rating(s) are green whileNVCT’s FA Score has 0 green FA rating(s).

  • KURA’s FA Score: 1 green, 4 red.
  • NVCT’s FA Score: 0 green, 5 red.
According to our system of comparison, NVCT is a better buy in the long-term than KURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KURA’s TA Score shows that 3 TA indicator(s) are bullish while NVCT’s TA Score has 3 bullish TA indicator(s).

  • KURA’s TA Score: 3 bullish, 6 bearish.
  • NVCT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, NVCT is a better buy in the short-term than KURA.

Price Growth

KURA (@Biotechnology) experienced а -6.12% price change this week, while NVCT (@Biotechnology) price change was -4.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

KURA is expected to report earnings on Mar 03, 2026.

NVCT is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KURA($814M) has a higher market cap than NVCT($215M). NVCT YTD gains are higher at: 11.391 vs. KURA (-9.913). NVCT has higher annual earnings (EBITDA): -26.41M vs. KURA (-212.24M). KURA has more cash in the bank: 550M vs. NVCT (35.4M). KURA has higher revenues than NVCT: KURA (104M) vs NVCT (0).
KURANVCTKURA / NVCT
Capitalization814M215M379%
EBITDA-212.24M-26.41M804%
Gain YTD-9.91311.391-87%
P/E RatioN/AN/A-
Revenue104M0-
Total Cash550M35.4M1,554%
Total Debt19.5MN/A-
FUNDAMENTALS RATINGS
KURA: Fundamental Ratings
KURA
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KURANVCT
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 7 days ago
77%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
88%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
KURA
Daily Signal:
Gain/Loss:
NVCT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IARAX16.270.13
+0.81%
Invesco Real Estate A
RPMIX9.870.05
+0.51%
Royce Small-Cap Fund Instl
ALSCX8.130.01
+0.12%
Alger Small Cap Growth B
WGUSX13.95-0.02
-0.14%
Wasatch US Select Inst
WSTRX51.38-0.70
-1.34%
Nomura Science and Technology R

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with XNCR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
+1.63%
XNCR - KURA
59%
Loosely correlated
+3.66%
CLDX - KURA
56%
Loosely correlated
+1.58%
NRIX - KURA
55%
Loosely correlated
+0.58%
VYGR - KURA
55%
Loosely correlated
+2.74%
IMNM - KURA
53%
Loosely correlated
+3.08%
More

NVCT and

Correlation & Price change

A.I.dvisor tells us that NVCT and MRVI have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVCT and MRVI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
+1.20%
MRVI - NVCT
32%
Poorly correlated
-1.99%
IBRX - NVCT
32%
Poorly correlated
+7.09%
GLMD - NVCT
30%
Poorly correlated
-0.83%
IMVT - NVCT
30%
Poorly correlated
+4.47%
KURA - NVCT
30%
Poorly correlated
+1.63%
More